医学
聚乙二醇干扰素
病毒学
慢性肝炎
干扰素
利巴韦林
免疫学
病毒
作者
Tarik Asselah,Vladimir Chulanov,Pietro Lampertico,Heiner Wedemeyer,Adrian Streinu‐Cercel,Victor Pântea,Ştefan Lazăr,Gheorghe Plăcintă,George Sebastian Gherlan,Pavel Bogomolov,T.V. Stepanova,Viacheslav Morozov,V. Е. Syutkin,Olga Sagalova,Dmitry Manuilov,Renée-Claude Mercier,Lei Ye,Ben L. Da,Grace M. Chee,Audrey Lau
标识
DOI:10.1056/nejmoa2314134
摘要
The combination of 10-mg bulevirtide plus peginterferon alfa-2a was superior to bulevirtide monotherapy with regard to an undetectable HDV RNA level at 24 weeks after the end of treatment. (Funded by Gilead Sciences; MYR 204 ClinicalTrials.gov number, NCT03852433.).
科研通智能强力驱动
Strongly Powered by AbleSci AI